Novartis as a focused innovative medicines company
Novartis is transforming into a ‘pure-play’ Innovative Medicines company.
Our focused strategy, core therapeutic areas, technology platforms, priority geographies and a deep, value-oriented pipeline are central to becoming the most valued and trusted medicines company in the world.
In a recent Meet Novartis Management Investor Relations session, Vas Narasimhan, Novartis Chief Executive Officer shared information on our refreshed strategy and approach to create value for our shareholders, patients, associates and society.
Meet Novartis Management
Event Date: September 22, 2022
Investors Page: https://bit.ly/3GR69sV
Link to Novartis Strategy: https://bit.ly/3D1U173
Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: https://bit.ly/3JaKJcK
Follow @Novartis on Twitter: http://twitter.com/Novartis
Follow Novartis on LinkedIn: http://www.linkedin.com/company/novartis
Видео Novartis as a focused innovative medicines company канала Novartis
Our focused strategy, core therapeutic areas, technology platforms, priority geographies and a deep, value-oriented pipeline are central to becoming the most valued and trusted medicines company in the world.
In a recent Meet Novartis Management Investor Relations session, Vas Narasimhan, Novartis Chief Executive Officer shared information on our refreshed strategy and approach to create value for our shareholders, patients, associates and society.
Meet Novartis Management
Event Date: September 22, 2022
Investors Page: https://bit.ly/3GR69sV
Link to Novartis Strategy: https://bit.ly/3D1U173
Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: https://bit.ly/3JaKJcK
Follow @Novartis on Twitter: http://twitter.com/Novartis
Follow Novartis on LinkedIn: http://www.linkedin.com/company/novartis
Видео Novartis as a focused innovative medicines company канала Novartis
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![From the Heart: Transforming healthcare systems](https://i.ytimg.com/vi/d9OguIUuz1U/default.jpg)
![Our Access Principles](https://i.ytimg.com/vi/DOyF_PUfRHc/default.jpg)
![Collaborating with AWS to accelerate our digital transformation](https://i.ytimg.com/vi/pVuFdNaTc6M/default.jpg)
![Kiss This 4 MBC: Novartis and Eva Longoria Raise Research Funds for MBC](https://i.ytimg.com/vi/0Q_nsvw9cX8/default.jpg)
![Together we can end malaria for good](https://i.ytimg.com/vi/LLmBhxlBKfU/default.jpg)
![The Beacons: Marion’s Story](https://i.ytimg.com/vi/AKbAA6Z2YOc/default.jpg)
![Chagas Chronic Cardiomyopathy](https://i.ytimg.com/vi/TWvP4EG4dH0/default.jpg)
![More Than a Milestone – Emily’s Story](https://i.ytimg.com/vi/4CbL76QI2ek/default.jpg)
![Living with neuroendocrine cancer – meet Kath](https://i.ytimg.com/vi/cWS0Tch8cE0/default.jpg)
![Reimagining leprosy elimination with AI analysis](https://i.ytimg.com/vi/uXUSQEKjpMw/default.jpg)
![Untold Stories of SCD: Unfiltered – Pt. 3 – Sights on Success](https://i.ytimg.com/vi/tb4LAVlA9-w/default.jpg)
![Protecting Our Tomorrows: Portraits of Meningococcal Disease: Danielle (Sydney, Australia)](https://i.ytimg.com/vi/EISV3LeE9kE/default.jpg)
![Strengthening commercial and R&D in the US](https://i.ytimg.com/vi/h13CttYwCMo/default.jpg)
![Environmental sustainability: a race we can win](https://i.ytimg.com/vi/LB2Yyy9cWYc/default.jpg)
![Talking malaria with Ben Rolfe](https://i.ytimg.com/vi/Bn8mZVVlG-k/default.jpg)
![Striving to eliminate malaria](https://i.ytimg.com/vi/6mfNCfsWxII/default.jpg)
![2021 NSofT Symposium: Rostom Ahmed-Belkacem, PhD](https://i.ytimg.com/vi/YP7Awwpuw_c/default.jpg)
![From the Heart: Getting to the bottom of the CVD crisis](https://i.ytimg.com/vi/FrSkFVyP5g8/default.jpg)
![Insights on expectations video Falchetto-Bushell](https://i.ytimg.com/vi/Y9W9ad6qJbk/default.jpg)
![Materiality Assessments – Building Trust with systematic stakeholder engagement](https://i.ytimg.com/vi/Ih1rIWyNzCs/default.jpg)
![Collaboration: The key to unlock new drugs](https://i.ytimg.com/vi/xHdfWtsWfC4/default.jpg)